| David C Carver, MD | |
|
340 Steeles Rd, Bristol, TN 37620 | |
| (423) 282-9011 | |
| Not Available |
| Full Name | David C Carver |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 340 Steeles Rd, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437492907 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watauga Orthopaedics Plc | 1456246479 | 62 |
News Archive
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
Chimeric antigen receptor T-cell therapy, or CAR T, was named the 2017 Advance of the Year by the American Society of Clinical Oncology. The FDA approved two CAR T products last year for treatment of adult large B-cell lymphoma based on the exceptional patient outcomes seen in clinical trials.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Entity Name | Watauga Orthopaedics Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245251404 PECOS PAC ID: 1456246479 Enrollment ID: O20040218000903 |
News Archive
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
Chimeric antigen receptor T-cell therapy, or CAR T, was named the 2017 Advance of the Year by the American Society of Clinical Oncology. The FDA approved two CAR T products last year for treatment of adult large B-cell lymphoma based on the exceptional patient outcomes seen in clinical trials.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David C Carver, MD 2410 Susannah St, Johnson City, TN 37601-1748 Ph: (423) 282-9011 | David C Carver, MD 340 Steeles Rd, Bristol, TN 37620 Ph: (423) 282-9011 |
News Archive
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
Chimeric antigen receptor T-cell therapy, or CAR T, was named the 2017 Advance of the Year by the American Society of Clinical Oncology. The FDA approved two CAR T products last year for treatment of adult large B-cell lymphoma based on the exceptional patient outcomes seen in clinical trials.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
› Verified 9 days ago
Natalie Huntington Vaughn, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd Ste 300e, Bristol, TN 37620 Phone: 423-844-6450 Fax: 423-844-6499 | |
Dr. Bert E Tagert, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1 Medical Park Blvd, Ste 300 E, Bristol, TN 37620 Phone: 423-844-6450 Fax: 423-844-6499 | |
Tyler M Duncan, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-280-9011 Fax: 423-282-0035 | |
Dr. Michael R Fleenor, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 260 Midway Medical Park, Ste 100, Bristol, TN 37620 Phone: 423-968-4446 Fax: 423-968-4802 | |
Dr. Richard Andrew Hillesheim, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 | |
Jonathan D Bryant, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 | |
Dr. Jason Allen Fogleman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 |